TY  - JOUR
AU  - Silvestre-Roig, Carlos
AU  - Fernandez, Patricia
AU  - Mansego, María L
AU  - van Tiel, Claudia M
AU  - Viana, Rosa
AU  - Anselmi, Chiara Viviani
AU  - Condorelli, Gianluigi
AU  - de Winter, Robbert J
AU  - Martín-Fuentes, Paula
AU  - Solanas-Barca, María
AU  - Civeira, Fernando
AU  - Focaccio, Amelia
AU  - de Vries, Carlie J M
AU  - Chaves, Felipe Javier
AU  - Andres, Vicente
PY  - 2014
DO  - 10.1161/CIRCGENETICS.113.000305
SN  - 1942-325X
UR  - http://hdl.handle.net/20.500.12105/7917
AB  - BACKGROUND: The development of diagnostic tools to assess restenosis risk after stent deployment may enable the intervention to be tailored to the individual patient, for example, by targeting the use of drug-eluting stent to high-risk patients, with...
LA  - eng
PB  - American Heart Foundation
KW  - AP-1 transcription factor
KW  - NF–Y transcription factor
KW  - SP1 transcription factor
KW  - In-stent restenosis
KW  - Polymorphism, genetics
KW  - Stents
KW  - Alleles
KW  - CCAAT-Binding Factor
KW  - Cohort Studies
KW  - Coronary Angiography
KW  - Coronary Restenosis
KW  - Cyclin B1
KW  - Genotype
KW  - Haplotypes
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Odds Ratio
KW  - Polymorphism, Single Nucleotide
KW  - Proportional Hazards Models
KW  - RNA, Messenger
KW  - Risk Factors
KW  - Sp1 Transcription Factor
KW  - Transcription Factor AP-1
KW  - Transcription, Genetic
KW  - Drug-Eluting Stents
TI  - Genetic variants in CCNB1 associated with differential gene transcription and risk of coronary in-stent restenosis
TY  - journal article
ER  -